These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3294012)

  • 1. Kawasaki disease: monitoring of circulating immune complexes.
    Salo E; Kekomäki R; Pelkonen P; Ruuskanen O; Viander M; Wagner O
    Eur J Pediatr; 1988 May; 147(4):377-80. PubMed ID: 3294012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of IgA-containing circulating immune complex and secretory IgA in Kawasaki disease.
    Ohshio G; Furukawa F; Khine M; Yoshioka H; Kudo H; Hamashima Y
    Microbiol Immunol; 1987; 31(9):891-8. PubMed ID: 3696008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes and granulocytes chemotaxis in Kawasaki disease.
    Miyata K; Kawakami K; Onimaru T; Baba Y; Ono S; Hokonohara M; Yoshinaga M; Terawaki T
    Jpn Circ J; 1984 Dec; 48(12):1350-3. PubMed ID: 6512943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of immunoglobulin on immune complexes in patients with Kawasaki disease (MCLS).
    Koike R
    Acta Paediatr Jpn; 1991 Jun; 33(3):300-9. PubMed ID: 1785324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IgG subclasses in the serum and circulating immune complexes in patients with Kawasaki disease].
    Li CR
    Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):578-81, 40. PubMed ID: 2620267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complex in the mucocutaneous lymph node syndrome.
    Furuse A; Matsuda I
    Eur J Pediatr; 1983 Oct; 141(1):50-1. PubMed ID: 6641766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin G subclasses in serum and circulating immune complexes in patients with Kawasaki syndrome.
    Li CR; Yang XQ; Shen J; Li YB; Jiang LP
    Pediatr Infect Dis J; 1990 Aug; 9(8):544-7. PubMed ID: 2235169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA; Dambuyant C; Thivolet J; Bussy R
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes in preeclampsia and normal pregnancy.
    Massobrio M; Benedetto C; Bertini E; Tetta C; Camussi G
    Am J Obstet Gynecol; 1985 Jul; 152(5):578-83. PubMed ID: 3893134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).
    Lin CY; Hwang B
    Ann Allergy; 1987 Oct; 59(4):291-7. PubMed ID: 3662131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin and circulating immune complexes in Behet's disease.
    Ozoran K; Düzgün N; Tutkak H; Gürler A; Tokgöz G
    Rheumatol Int; 1996; 15(6):221-4. PubMed ID: 8778949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.
    Levin M; Holland PC; Nokes TJ; Novelli V; Mola M; Levinsky RJ; Dillon MJ; Barratt TM; Marshall WC
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1456-60. PubMed ID: 3922532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of platelet fc and complement receptors with circulating immune complexes involving the AB0 system.
    Heal JM; Masel D; Blumberg N
    Vox Sang; 1996; 71(4):205-11. PubMed ID: 8958643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of circulating immune complexes during the evolution of visceral Mediterranean leishmaniasis.
    Makni S; Ayed K; Ben Said M; Ben Rachid MS
    Ann Trop Med Parasitol; 1989 Aug; 83(4):349-55. PubMed ID: 2532497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between secretory IgA, IgA-containing (C3-fixing) circulating immune complexes, and complement components (C3, C4) in patients with obstructive jaundice.
    Ohshio G; Furukawa F; Manabe T; Tobe T; Hamashima Y
    Scand J Gastroenterol; 1986 Mar; 21(2):151-7. PubMed ID: 3715384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-associated IgG, IgM, and C3 in paediatric infectious disease.
    Forster J; Katzikadamos Z; Zinn P
    Helv Paediatr Acta; 1989 Jun; 43(5-6):415-22. PubMed ID: 2745137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular weights of IgA-circulating immune complexes (CIC) in patients with IgA nephropathy: application of HPLC and solid-phase anti-C3 Facb EIA.
    Eguchi K; Tomino Y; Yagame M; Nomoto Y; Sakai H; Suguki H; Hosoda K
    Tokai J Exp Clin Med; 1988 Feb; 13(1):9-13. PubMed ID: 3068839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.